RSS app

Breaking News

It’s not too late! CDC & FDA workshop has spots left

Latest from CDC on Antibiotic Resistance (AR)

Join Us to Talk Products for Patient Safety

Experts from CDC, FDA, academia & industry discuss product development to combat healthcare-associated infections

There is still time to register for next Tuesday’s Drug Development Considerations for the Prevention of Healthcare-Associated Infections public workshop, co-sponsored by CDC and the Food & Drug Administration (FDA).


Join experts from CDC, FDA, academic researchers, patient representatives, and private industry to discuss:

  • The current state of development of pathogen-directed products used to prevent healthcare-associated infections (HAIs)
  • Evidence supporting decolonization and pathogen reduction (in colonized patients) as a strategy to prevent infection and transmission of antimicrobial-resistant healthcare-associated pathogens
  • Antimicrobial resistance threats as potential targets for decolonization and pathogen reduction
  • Challenges and potential approaches to drug development and registration of products for the prevention of healthcare-associated infections

Drug Development Considerations for the Prevention of Healthcare-Associated Infections—Virtual Public Workshop Co-sponsored by CDC & FDA; Date: August 30, 2022; Time: 8:30 a.m. to 5 p.m. The logos for CDC and FDA are in the lower right corner.
Register

Join me at next week’s @CDC_AR and @US_FDA workshop on products to prevent healthcare-associated infections and combat #AntimicrobialResistance. Registration: https://bit.ly/3xwoA2t 


Share On Twitter

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |  Unsubscribe

No comments

My Blog List

pages

Pages

Popular Posts

Popular Posts